Global Postoperative Nausea and Vomiting (PONV) Market Insights, Forecast to 2031

Report ID: 1653734 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Serotonin Antagonists
        1.2.3 Steroids
        1.2.4 Dopamine Antagonists
        1.2.5 NK-1 Receptor Antagonists
        1.2.6 Non-pharmacologic Treatment
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Online Pharmacies
        1.3.4 Retail Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Postoperative Nausea and Vomiting (PONV) Market Perspective (2017-2028)
    2.2 Postoperative Nausea and Vomiting (PONV) Growth Trends by Region
        2.2.1 Postoperative Nausea and Vomiting (PONV) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Postoperative Nausea and Vomiting (PONV) Historic Market Size by Region (2017-2022)
        2.2.3 Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Region (2023-2028)
    2.3 Postoperative Nausea and Vomiting (PONV) Market Dynamics
        2.3.1 Postoperative Nausea and Vomiting (PONV) Industry Trends
        2.3.2 Postoperative Nausea and Vomiting (PONV) Market Drivers
        2.3.3 Postoperative Nausea and Vomiting (PONV) Market Challenges
        2.3.4 Postoperative Nausea and Vomiting (PONV) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue
        3.1.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue (2017-2022)
        3.1.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Players (2017-2022)
    3.2 Global Postoperative Nausea and Vomiting (PONV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Postoperative Nausea and Vomiting (PONV) Revenue
    3.4 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio
        3.4.1 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Postoperative Nausea and Vomiting (PONV) Revenue in 2021
    3.5 Postoperative Nausea and Vomiting (PONV) Key Players Head office and Area Served
    3.6 Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
    3.7 Date of Enter into Postoperative Nausea and Vomiting (PONV) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Type
    4.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Type (2017-2022)
    4.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2023-2028)
5 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Application
    5.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Application (2017-2022)
    5.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Postoperative Nausea and Vomiting (PONV) Market Size (2017-2028)
    6.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Type
        6.2.1 North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017-2022)
        6.2.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2023-2028)
        6.2.3 North America Postoperative Nausea and Vomiting (PONV) Market Share by Type (2017-2028)
    6.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Application
        6.3.1 North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017-2022)
        6.3.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2023-2028)
        6.3.3 North America Postoperative Nausea and Vomiting (PONV) Market Share by Application (2017-2028)
    6.4 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country
        6.4.1 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2017-2022)
        6.4.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size (2017-2028)
    7.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type
        7.2.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017-2022)
        7.2.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2023-2028)
        7.2.3 Europe Postoperative Nausea and Vomiting (PONV) Market Share by Type (2017-2028)
    7.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application
        7.3.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017-2022)
        7.3.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2023-2028)
        7.3.3 Europe Postoperative Nausea and Vomiting (PONV) Market Share by Application (2017-2028)
    7.4 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country
        7.4.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2017-2022)
        7.4.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size (2017-2028)
    8.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type
        8.2.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Type (2017-2028)
    8.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application
        8.3.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Application (2017-2028)
    8.4 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region
        8.4.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size (2017-2028)
    9.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type
        9.2.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017-2022)
        9.2.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2023-2028)
        9.2.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Share by Type (2017-2028)
    9.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application
        9.3.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017-2022)
        9.3.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2023-2028)
        9.3.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Share by Application (2017-2028)
    9.4 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country
        9.4.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2017-2022)
        9.4.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size (2017-2028)
    10.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type
        10.2.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Share by Type (2017-2028)
    10.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application
        10.3.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Share by Application (2017-2028)
    10.4 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country
        10.4.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Acacia Pharma
        11.1.1 Acacia Pharma Company Details
        11.1.2 Acacia Pharma Business Overview
        11.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Introduction
        11.1.4 Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
        11.1.5 Acacia Pharma Recent Developments
    11.2 F. Hoffmann-La Roche
        11.2.1 F. Hoffmann-La Roche Company Details
        11.2.2 F. Hoffmann-La Roche Business Overview
        11.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Introduction
        11.2.4 F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
        11.2.5 F. Hoffmann-La Roche Recent Developments
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Introduction
        11.3.4 Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
        11.3.5 Novartis Recent Developments
    11.4 Ani Pharmaceuticals
        11.4.1 Ani Pharmaceuticals Company Details
        11.4.2 Ani Pharmaceuticals Business Overview
        11.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Introduction
        11.4.4 Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
        11.4.5 Ani Pharmaceuticals Recent Developments
    11.5 Camurus
        11.5.1 Camurus Company Details
        11.5.2 Camurus Business Overview
        11.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Introduction
        11.5.4 Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
        11.5.5 Camurus Recent Developments
    11.6 Sanofi
        11.6.1 Sanofi Company Details
        11.6.2 Sanofi Business Overview
        11.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Introduction
        11.6.4 Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
        11.6.5 Sanofi Recent Developments
    11.7 Helsinn Holding
        11.7.1 Helsinn Holding Company Details
        11.7.2 Helsinn Holding Business Overview
        11.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Introduction
        11.7.4 Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
        11.7.5 Helsinn Holding Recent Developments
    11.8 Eisai
        11.8.1 Eisai Company Details
        11.8.2 Eisai Business Overview
        11.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Introduction
        11.8.4 Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
        11.8.5 Eisai Recent Developments
    11.9 Merck
        11.9.1 Merck Company Details
        11.9.2 Merck Business Overview
        11.9.3 Merck Postoperative Nausea and Vomiting (PONV) Introduction
        11.9.4 Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
        11.9.5 Merck Recent Developments
    11.10 GlaxoSmithKline
        11.10.1 GlaxoSmithKline Company Details
        11.10.2 GlaxoSmithKline Business Overview
        11.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Introduction
        11.10.4 GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
        11.10.5 GlaxoSmithKline Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Serotonin Antagonists
    Table 3. Key Players of Steroids
    Table 4. Key Players of Dopamine Antagonists
    Table 5. Key Players of NK-1 Receptor Antagonists
    Table 6. Key Players of Non-pharmacologic Treatment
    Table 7. Key Players of Others
    Table 8. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 9. Global Postoperative Nausea and Vomiting (PONV) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Postoperative Nausea and Vomiting (PONV) Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Postoperative Nausea and Vomiting (PONV) Market Share by Region (2017-2022)
    Table 12. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Postoperative Nausea and Vomiting (PONV) Market Share by Region (2023-2028)
    Table 14. Postoperative Nausea and Vomiting (PONV) Market Trends
    Table 15. Postoperative Nausea and Vomiting (PONV) Market Drivers
    Table 16. Postoperative Nausea and Vomiting (PONV) Market Challenges
    Table 17. Postoperative Nausea and Vomiting (PONV) Market Restraints
    Table 18. Global Postoperative Nausea and Vomiting (PONV) Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Players (2017-2022)
    Table 20. Global Top Postoperative Nausea and Vomiting (PONV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2021)
    Table 21. Ranking of Global Top Postoperative Nausea and Vomiting (PONV) Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
    Table 25. Date of Enter into Postoperative Nausea and Vomiting (PONV) Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2017-2022)
    Table 29. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2023-2028)
    Table 31. Global Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Application (2017-2022)
    Table 33. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Application (2023-2028)
    Table 35. North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017-2022) & (US$ Million)
    Table 36. North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2023-2028) & (US$ Million)
    Table 37. North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017-2022) & (US$ Million)
    Table 38. North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2023-2028) & (US$ Million)
    Table 39. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2017-2022) & (US$ Million)
    Table 40. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017-2022) & (US$ Million)
    Table 42. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2023-2028) & (US$ Million)
    Table 43. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017-2022) & (US$ Million)
    Table 44. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2023-2028) & (US$ Million)
    Table 45. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2017-2022) & (US$ Million)
    Table 46. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2023-2028) & (US$ Million)
    Table 53. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017-2022) & (US$ Million)
    Table 54. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2023-2028) & (US$ Million)
    Table 55. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017-2022) & (US$ Million)
    Table 56. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2023-2028) & (US$ Million)
    Table 57. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2017-2022) & (US$ Million)
    Table 58. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2028) & (US$ Million)
    Table 65. Acacia Pharma Company Details
    Table 66. Acacia Pharma Business Overview
    Table 67. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product
    Table 68. Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
    Table 69. Acacia Pharma Recent Developments
    Table 70. F. Hoffmann-La Roche Company Details
    Table 71. F. Hoffmann-La Roche Business Overview
    Table 72. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product
    Table 73. F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
    Table 74. F. Hoffmann-La Roche Recent Developments
    Table 75. Novartis Company Details
    Table 76. Novartis Business Overview
    Table 77. Novartis Postoperative Nausea and Vomiting (PONV) Product
    Table 78. Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
    Table 79. Novartis Recent Developments
    Table 80. Ani Pharmaceuticals Company Details
    Table 81. Ani Pharmaceuticals Business Overview
    Table 82. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product
    Table 83. Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
    Table 84. Ani Pharmaceuticals Recent Developments
    Table 85. Camurus Company Details
    Table 86. Camurus Business Overview
    Table 87. Camurus Postoperative Nausea and Vomiting (PONV) Product
    Table 88. Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
    Table 89. Camurus Recent Developments
    Table 90. Sanofi Company Details
    Table 91. Sanofi Business Overview
    Table 92. Sanofi Postoperative Nausea and Vomiting (PONV) Product
    Table 93. Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
    Table 94. Sanofi Recent Developments
    Table 95. Helsinn Holding Company Details
    Table 96. Helsinn Holding Business Overview
    Table 97. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product
    Table 98. Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
    Table 99. Helsinn Holding Recent Developments
    Table 100. Eisai Company Details
    Table 101. Eisai Business Overview
    Table 102. Eisai Postoperative Nausea and Vomiting (PONV) Product
    Table 103. Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
    Table 104. Eisai Recent Developments
    Table 105. Merck Company Details
    Table 106. Merck Business Overview
    Table 107. Merck Postoperative Nausea and Vomiting (PONV) Product
    Table 108. Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
    Table 109. Merck Recent Developments
    Table 110. GlaxoSmithKline Company Details
    Table 111. GlaxoSmithKline Business Overview
    Table 112. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product
    Table 113. GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2017-2022) & (US$ Million)
    Table 114. GlaxoSmithKline Recent Developments
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Postoperative Nausea and Vomiting (PONV) Market Share by Type: 2021 VS 2028
    Figure 2. Serotonin Antagonists Features
    Figure 3. Steroids Features
    Figure 4. Dopamine Antagonists Features
    Figure 5. NK-1 Receptor Antagonists Features
    Figure 6. Non-pharmacologic Treatment Features
    Figure 7. Others Features
    Figure 8. Global Postoperative Nausea and Vomiting (PONV) Market Share by Application: 2021 VS 2028
    Figure 9. Hospital Pharmacies Case Studies
    Figure 10. Online Pharmacies Case Studies
    Figure 11. Retail Pharmacies Case Studies
    Figure 12. Postoperative Nausea and Vomiting (PONV) Report Years Considered
    Figure 13. Global Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Postoperative Nausea and Vomiting (PONV) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Postoperative Nausea and Vomiting (PONV) Market Share by Region: 2021 VS 2028
    Figure 16. Global Postoperative Nausea and Vomiting (PONV) Market Share by Players in 2021
    Figure 17. Global Top Postoperative Nausea and Vomiting (PONV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue in 2021
    Figure 19. North America Postoperative Nausea and Vomiting (PONV) Market Size YoY (2017-2028) & (US$ Million)
    Figure 20. North America Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2017-2028)
    Figure 21. North America Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2017-2028)
    Figure 22. North America Postoperative Nausea and Vomiting (PONV) Market Size Share by Country (2017-2028)
    Figure 23. United States Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Postoperative Nausea and Vomiting (PONV) Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. Europe Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2017-2028)
    Figure 27. Europe Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2017-2028)
    Figure 28. Europe Postoperative Nausea and Vomiting (PONV) Market Size Share by Country (2017-2028)
    Figure 29. Germany Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. France Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. U.K. Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Italy Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Russia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Nordic Countries Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size YoY (2017-2028) & (US$ Million)
    Figure 36. Asia Pacific Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Postoperative Nausea and Vomiting (PONV) Market Size Share by Region (2017-2028)
    Figure 39. China Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Japan Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. South Korea Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. India Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Australia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 45. Latin America Postoperative Nausea and Vomiting (PONV) Market Size YoY (2017-2028) & (US$ Million)
    Figure 46. Latin America Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2017-2028)
    Figure 47. Latin America Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2017-2028)
    Figure 48. Latin America Postoperative Nausea and Vomiting (PONV) Market Size Share by Country (2017-2028)
    Figure 49. Mexico Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Brazil Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Type (2017-2028)
    Figure 53. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Market Size Market Share by Application (2017-2028)
    Figure 54. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Market Size Share by Country (2017-2028)
    Figure 55. Turkey Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. UAE Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Acacia Pharma Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
    Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
    Figure 60. Novartis Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
    Figure 61. Ani Pharmaceuticals Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
    Figure 62. Camurus Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
    Figure 63. Sanofi Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
    Figure 64. Helsinn Holding Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
    Figure 65. Eisai Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
    Figure 66. Merck Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
    Figure 67. GlaxoSmithKline Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Acacia Pharma
F. Hoffmann-La Roche
Novartis
Ani Pharmaceuticals
Camurus
Sanofi
Helsinn Holding
Eisai
Merck
GlaxoSmithKline
Frequently Asked Questions
Postoperative Nausea and Vomiting (PONV) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Postoperative Nausea and Vomiting (PONV) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Postoperative Nausea and Vomiting (PONV) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Constipation

Constipation market is segmented by players, region (country), by Type and by Application. Player ... Read More

Continence Care

Continence Care market is segmented by players, region (country), by Type and by Application. Pla ... Read More

Depressive Disorder

Depressive Disorder market is segmented by players, region (country), by Type and by Application. ... Read More